Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted) (2019 - 2026)
Assembly Biosciences (ASMB) recorded quarterly EPS (Weighted Average and Diluted) of -$0.54 in Q1 2026, down 121.77% quarter-over-quarter from $2.48 in Q4 2025, and up 53.85% on a YoY basis from -$0.35 in Q1 2025.
Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
Assembly Biosciences' EPS (Weighted Average and Diluted) history runs 8 years deep, the most recent figure standing at -$0.54 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 53.85% year-over-year to -$0.54; the TTM figure through Mar 2026 stood at -$0.11 (up 98.23% YoY), while the FY2025 annual figure was -$0.55, up 91.78% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.54 for Q1 2026 at Assembly Biosciences, down from $2.48 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.48 in Q4 2025 to a low of -$21.62 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$2.62 across 5 years, with a median of -$1.51 in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) plunged 1478.1% in 2022, then soared 257.96% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$21.62 in 2022, then jumped by 91.81% to -$1.77 in 2023, then gained by 11.3% to -$1.57 in 2024, then jumped by 257.96% to $2.48 in 2025, then tumbled by 121.77% to -$0.54 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.54 (Q1 2026), $2.48 (Q4 2025), and -$0.72 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -0.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.54 |
| Dec 31, 2025 | 2.48 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -1.17 |
| Dec 31, 2024 | -1.57 |
| Sep 30, 2024 | -1.51 |
| Jun 30, 2024 | -1.98 |
| Mar 31, 2024 | -1.66 |
| Dec 31, 2023 | -1.77 |
| Sep 30, 2023 | -3.29 |
| Jun 30, 2023 | -3.88 |
| Mar 31, 2023 | -4.46 |
| Dec 31, 2022 | -21.62 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.51 |
| Mar 31, 2022 | -0.48 |
| Dec 31, 2021 | -1.37 |
| Sep 30, 2021 | -0.41 |
| Jun 30, 2021 | -0.55 |